Our group and others have previously reported the ability of EGFL6 to promote ovarian tumorigenesis by increasing angiogenesis, stimulating cancer cell asymmetric division and inducing migration and cancer cell metastasis (26, 29, 32, 33, 42). Here, EGFL6 is linked to cancer.